Patent published on October 5, 2023

New Patent Might Morph Vicks Products into Virus Stoppers

When one thinks of a common cold or flu, the image of using Vicks VapoRub or a throat spray perhaps comes to mind. A sniffle here, a cough there, and we are rushing to grab these trusted products. But now, a recently published patent might redefine how these products work in the future.

Imagine a world where your everyday health care products like VapoRub or nasal spray are not just alleviating symptoms like a stuffy nose or a sore throat, but they are actively working against the viruses that cause these symptoms. This might soon be a reality if a patent with the number US20230313201A1 comes to fruition.

The central problem being solved by this patent is our constant battle against viruses. Medicine has traditionally reacted to viruses, by treating the symptoms they cause but the patent purpose proposes a more proactive solution. This patent revolves around a unique concoction known as an "aptamer." It’s a special mix that can bind to specific regions of our body cells, stopping certain viruses from latching onto our cells and thus preventing us from falling sick.

This proactive solution is highly necessary, especially as viruses continue to evolve into various strains. Rhinoviruses, in particular, cause millions of cases of the common cold each year, leading to lost workdays and school absences.

Going by the details of the patent, this innovative solution involves using methods that help identify these aptamers which can then be used to prevent the binding of rhinoviruses, thus mitigating symptoms or even stopping reinfections.

And once this problem is solved, we can imagine a world where every rub of that Vicks VapoRub or a quick spray inside our noses is a step in preventing viral infections, rather than just a way to soothe symptoms.

But let’s remember, these are only potential benefits. This being a patent means it's still a theoretical concept, and there is no certainty yet whether it will definitely appear in the market or not. The figures given in the patent show the extent of thought and work that has gone into materializing this idea, but real-world applications may see more challenges to overcome.

In the end, if this patent does get incorporated into health care products in the future, it could be a game-changer in preventing common viral infections, resulting in healthier lives for all of us.

Explore more